Last Updated on November 27, 2021 by The Health Master
Diversified entity ITC on Thursday confirmed that it is developing a nasal spray for COVID-19 prevention for which it has initiated clinical trials.
Developed by scientists at ITC Life Sciences and Technology Centre (LSTC), Bengaluru, the company plans to market the nasal spray under the Savlon brand once it gets all the requisite regulatory approvals, according to sources.
When contacted for comments, a spokesperson for ITC said, “We are unable to share more details at the current moment as the clinical trials are underway.”
The spokesperson declined to comment on a detailed query on where the clinical trial is being done, when the commercial production would be done if approved and under what brand the nasal spray would be marketed.
However, sources said the company had received approval from ethics committees and is registered with Clinical Trial Registry-India (CTRI) for clinical trials of the nasal spray which is designed to arrest the virus at the entry point in the nasal cavity itself.
They further said the product has the potential to be effective and safe in preventing infection and transmission of COVID-19 along with the existing measures of hygiene recommended by health authorities.
ITC’s LSTC has been at the core of the company’s drive for science led product innovation to support and build its wide range of product portfolio.
The company’s R&D teams were instrumental in developing a range of innovative health and hygiene offerings that were commercially made available under the Savlon brand, during the pandemic.
Notifications: New Drugs, FDC, Clinical Trial
Other details about New Drugs, FDCs, Clinical trial
Govt appoints Deepak Gaikwad as State Licensing Authority FDA Karnataka
Govt: These agencies can conduct studies on Pharma & Medical Devices
CDSCO Panel gives nod to Sun Pharma’s Dapagliflozin, Glimepiride, Metformin FDC
Cost of Raw Materials for Drugs increased from 11% to 51%
New asthma drug approved on NHS branded a ‘Wonder Drug’
World’s biggest Vegetarian Capsules plant to come in India
CDSCO approves this Diabetes Tablet for use against Heart Failure
Govt endorses these suggestions to amend D&C Act and DPCO
2 lakh Pharmacies in India by next year: Biddano
Latest Notifications regarding Pharmaceuticals
For informative videos by The Health Master, click on the below YouTube icon:
For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos on consumer awareness, click on the below YouTube icon:
